Helicobacter Pylori Testing Market Report: Overview With Geographical Segmentation By Revenue With Forecast By 2032

 By the end of 2022, it is anticipated that the global helicobacter pylori testing market will be worth US$173.1 Million. A CAGR of 7.4% has been predicted for the market over the forecast period of 2022 to 2032, with a predicted closing value of US$ 380.3 Million. The industry expanded at a value CAGR of 6.2% throughout the historical period of 2016–2021.

Helicobacter Pylori Testing Market: Drivers and Restraints

Over the forecast period, the global helicobacter pylori testing market is expected to grow steadily because of the increasing number of older population, and increased prevalence of infectious diseases and gastritis.

The growing awareness of immunodiagnostics among the people, rapid advances in technology and innovations, and increasing product approvals are expected to propel the market growth of the global helicobacter pylori testing market. However high cost of test is the prominent factors restraining the growth of global helicobacter pylori testing market.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5276 

Helicobacter Pylori Testing Market: Overview

To evaluate the effectiveness of the treatment and diagnose an infection helicobacter pylori testing is done. The tests with endoscopy is considered good tests but are invasive so they are less frequently ordered. Based on end user, the global helicobacter pylori testing is segmented into hospitals, private labs, public’s health labs and physician offices.

The Helicobacter pylori testing is used to identify a helicobacter pylori infection in the upper part of the small intestine and stomach. The helicobacter pylori test is also used to evaluate the effectiveness of the treatment. Helicobacter pylori can cause peptic ulcers, stomach (gastric) cancer and chronic gastritis.

Helicobacter pylori testing is done to find whether an infection with helicobacter pylori bacteria is causing an ulcer or not. There are different types of helicobacter pylori testing that are performed. Amongst them some requires a sample of stool or breath while others are more invasive and requires a tissue sample obtained using an endoscopy.

Helicobacter pylori bacteria grows in the digestive tract and have a tendency to attack the stomach lining. Helicobacter pylori infections are usually harmless but they are mainly responsible for majority of ulcers in the small intestine and stomach. It is the most common infection in humans therefore there detection is important.

According to a research by CDC, helicobacter pylori causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers

Speak to our Research Expert @ https://www.futuremarketinsights.com/askus/rep-gb-5276 

Helicobacter Pylori Testing Market: Regional Overview

Geographically, global helicobacter pylori testing market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global helicobacter pylori testing market over the forecast period due to high prevalence of gastritis. Western Europe is expected to be the second largest market for helicobacter pylori testing. Asia Pacific market is expected to experience delayed growth due to unawareness towards helicobacter pylori testing and low disposable income.

Helicobacter Pylori Testing Market

Key Players

Some of the players identified in global helicobacter pylori testing market include Abbott, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd., Sekisui Diagnostics, LLC, etc.

Helicobacter Pylori Testing Market: Segmentation

The global helicobacter pylori testing market is classified on the basis of test type, end user and geography.

On the basis of test type, the global helicobacter pylori testing market can be segmented into:

  • With Endoscopy
  • Histology
  • Rapid urease testing
  • Culture
  • PCR (Polymerase Chain Reaction)
  • Without Endoscopy
  • Stool/fecal antigen test
  • Urea breath test
  • H. pylori antibody testing

On the basis of end user, the global helicobacter pylori testing market can be segmented into:

  • Hospitals
  • Private Labs
  • Public health labs
  • Physician offices

Comments

Post a Comment

Popular posts from this blog

Mammography Market Demand, Scope and Future Estimation until 2032

  The global  mammography market    is estimated to be worth around  US$ 1.7 Billion  in 2022. However, with rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around  6.5%  to  9% CAGR  between 2022 and 2032, totaling over  US$ 3.4 Billion  by 2032. Mammography  is a modern non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to monitor breast tissues for the presence of tumor. It has become one of the most commonly used techniques for checking abnormalities in the absence of any symptoms. It has significantly aided in reducing breast cancer mortality rates worldwide. Increasing prevalence of breast cancer across the world along with growing awareness about the benefits of screening and early diagnosis of breast cancer is providing a major impetus to the growth of mammography market. It is one of the most common forms of cancer among females, worldwide. Various studies have found that t
Read more

Interventional Cardiology Devices Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The  interventional cardiology devices market demand  is expected to grow at an  8.4%  CAGR from  USD 16.4  Billion in 2022 to USD  36.9  Billion by 2032. The fast expansion of the geriatric population and the corresponding increase in the prevalence of coronary artery diseases, the approval of new and sophisticated products, and the growing incidence of diabetes are all driving growth in the interventional cardiology devices market. However, the availability of alternative therapies, as well as product failures and recalls, are the primary factors projected to hinder interventional cardiology devices market growth over the projection period. COVID-19 has had a global influence on every element of the medical device business, including the market for interventional cardiology equipment. Despite the fact that emergency and outpatient treatments are offered in cardiology departments, the number of patient visits to hospitals has decreased dramatically in the last six months. Patient vi
Read more

Cardiac Rehabilitation Market Research, Segmentation, Key Players Analysis & Forecast By 2032

  The  cardiac rehabilitation market share  is likely to expand its roots in the global market at an average CAGR of 6.0% between 2022 and 2032. The market is valued at US$ 2.1 Bn in 2022 and is likely to reach US$ 3.8 Bn by 2032. Previously, the market was thriving at a slightly higher CAGR of 6.5% (2015-2021), ensuring a market size of US$ 2 Billion in 2021. “Growing lifestyle-related diseases like diabetes and cardiovascular strokes along with the technological revolution in the healthcare sector, helping the patients going through heart attack, heart valve surgeries, heart failures.” An unhealthy lifestyle is leading to new heart-related diseases like heart attacks and heart failure. The technologically advanced tools that enable easy surgery processes drive the sales of cardiac rehabilitation systems. These systems help end users with exercises, diet, stress management and training, managing and monitoring the daily progress of the health routine. It is largely consumed by The new
Read more